Skip to main content
. Author manuscript; available in PMC: 2015 Nov 11.
Published in final edited form as: Bioconjug Chem. 2014 Nov 24;25(12):2197–2204. doi: 10.1021/bc500415x

Figure 1.

Figure 1

Generation of Cetuximab-Fab and its characterization. (A) Schematic diagram for Cetuximab-Fab generation from intact antibody, conjugation and radiolabeling. The figures are not drawn to scale. (B) SDS-PAGE to confirm the purity of Cetuximab-Fab (lane 1: ladder, lane 2: intact Cetuximab; lane 3: unpurified Cetuximab-Fab after papain digestion and lane 4: purified Cetuximab-Fab after passing through Protein A column). (C) Mass spectrometry of Cetuximab-Fab (~ 49.9 kDa).